Add a new dimension of insights
to your view of cancer with Guardant Infinity™
The epigenome can help explain diverse phenotypes that do not harbor genetic variation1
Genomics alone is a narrow view of cancer, and epigenomic insights are critical
to understanding
cancer biology that genomics alone cannot elucidate.2,3
>
In the past 8 years, up to 42%
of FDA-approved therapies were personalized medicines.4
However, among all patients
with cancer, >80% are still ineligible
for genomic precision
medicine approaches.5
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma